Experimental Novartis leukaemia and mastocytosis drug gets FDA Priority Review
November 14, 2016Research and Development, Sales and Marketing FDA, Novartis, acute myeloid leukaemia
The US FDA has granted Priority Review status to Novartis’ experimental drug PKC412 (midostaurin) as a treatment for advanced systemic …
Pfizer’s Celebrex found to be safe on hearts after 10-year clinical study
November 14, 2016Medical Communications, Sales and Marketing Pfizer, celebrex, ibuprofen, naproxen
Pfizer’s drug, Celebrex, has been vindicated as of equivalent safety, or better, than ibuprofen and naproxen, after a 10-year study. …
GSK emerges top of the pile for improving access to medicine
November 14, 2016Medical Communications, Sales and Marketing Access to Medicine Index, GSK, market access, pricing
GlaxoSmithKline, the British drugmaker, has topped the overall ranking of the Access to Medicine Index, which ranks 20 top pharmaceutical …
Top Ten articles in the Pharma Industry this week
November 11, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing November, news, pharmaceutical, top 10, top ten, top ten stories
This week has seen pharmaceutical companies defending their patent protections and host of new collaboration spring up between companies. Read …
Almac Group announces £27 million global expansion
November 11, 2016Medical Communications, Sales and Marketing Almac Group, investment
Almac Group, a global contract pharmaceutical development and manufacturing organisation, has announced that it will spend £27 million in a …
Bionical adds Emas Pharma in strategic acquisition
November 11, 2016Medical Communications, Sales and Marketing Bionical, Emas pharma, acquistion
Bionical, an integrated outsourced specialist to the pharmaceutical, biotechnology and public health industry, has announced the acquisition of Emas Pharma. …
Alexion begins internal probe into sales practices
November 11, 2016Medical Communications Alexion, sales practices
Alexion Pharmaceuticals released a statement that it was to begin conducting an internal investigation into sales practices for Soliris (eculizumb) …
Proposition 61 defeated to allay changes on drug pricing
November 11, 2016Medical Communications Bernie Sanders, Drug pricing, Proposition 61, california
Another major piece of voting news emerged on 9 November, with Proposition 61 voted down by Californian residents, with the …
Former Roche CEO joins Arix Bioscience as senior independent director
November 10, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Arix Bioscience, a Britain-based healthcare and life science company, appointed Franz Humer as a senior independent director on 31 October. …
Court of Appeal rules that the NHS can legally fund HIV-prevention drug PrEP
November 10, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Court of Appeals, Gilead, NHS England, Truvada, high court
A High Court ruling that NHS England was legally responsible for preventing the spread of HIV has been upheld when …
Social media and mobile apps: Bringing people and clinical trials together
November 10, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
In part one, we looked at the difficulty in recruiting and retaining patients for clinical trials, and how increased communication …
Pfizer’s breast cancer drug gets EU approval
November 10, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, Novartis, Pfizer, ibrance
Pfizer is celebrating the approval by the European Union of its breast cancer drug Ibrance, following a positive recommendation from …
Novavax cuts works force by a third in struggle to restructure
November 10, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cost cutting, Jobs, Novavax, losses
Novavax released the news that it would cut away 30% of its workforce alongside third quarter results that revenues were …
Chinese FDA releases “drug scanner” app
November 10, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Food and Drug Administration, app
The China Food and Drug Administration (CFDA) has released a new app earlier this week which enables users to download …
Collaboration on new therapeutic vaccine for HIV shows promise
November 10, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HIV, J&J, JJ, Janssen, Johnson & Johnson
Janssen, part of Johnson & Johnson, released details on 9 November of the results of a new study looking into …
Pfizer to shut two out of three manufacturing plants in UK
November 9, 2016Manufacturing and Production, Research and Development Pfizer, UK, manufacturing, production, sites
Pfizer has announced that it will close two of the three manufacturing plants it still holds in the UK. The …
NICE turns down Amgen’s multiple myeloma drug
November 9, 2016Research and Development, Sales and Marketing Amgen, Kyprolis, NICE
Amgen has seen its drug Kyprolis (carfilzomib) rejected by NICE for its routine use in the treatment of multiple myeloma …
Valeant’s tough year gets worse with Q3 loss of $1.22 billion
November 9, 2016Research and Development Q3, Valeant, loss
It’s easy to say that Valeant hasn’t had a great year so far. Unfortunately for those concerned, the outlook for …
BenevolentAI announces licensing agreement with Janssen
November 8, 2016Research and Development Janssen, Johnson & Johnson, artificial intelligence
BenevolentAI, a British artificial intelligence company, announced a licensing agreement to develop a select number of drug candidates with Janssen, …
Irina Antonijevic appointed as chief medical officer at vasopharm
November 8, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
vasopharma, a privately held biopharmaceutical company, announced on 8 November that it had appointed Irina Antonijevic as their chief medical …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
